Fourth International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation

Chicago, IL US
September 21, 2018 to September 22, 2018
Relapse and disease progression are the leading causes of treatment failure for most hematologic malignancies treated with both allogeneic and autologous hematopoietic stem cell transplantation (HSCT). This symposium continues to grow and evolve from achievements of the first three Workshops, as we have witnessed tremendous progress in our understanding and treatment of relapse in the past 12 years. As such, the planned objectives of the fourth workshop are designed to present the latest scientific and clinical advances related to relapse after HSCT and to provide a forum for the presentation of ongoing laboratory, translational, and clinical research specifically related to this field.

The workshop will feature internationally-recognized speakers from a multidisciplinary, diverse group comprised of basic and translational scientists and clinical investigators. The Workshop will include formal didactic presentations and informal discussion panels. It will also offer investigators interested in the field the opportunity to present their work in dedicated oral and poster sessions.

Target Audience

This activity has been designed for medical and pediatric hematologists-oncologists, hematopoietic stem and immune cell translational and basic scientists, hematopathologists, physicians-in-training (Fellows/Residents/Post Docs), advance practice providers, pharmacists, oncology nurses and other associated allied health professionals.

Learning Objectives

At the conclusion of this course, the participants should be able to:

  • Update the current state of the science relative to biology and clinical study of relapse related to both autologous and allogeneic HSCT;
  • Provide a forum for the presentation of ongoing laboratory and translational research specifically related to relapse following HSCT;
  • Provide a forum to present ongoing clinical trials that are specific to the study of and treatment of relapse following HSCT;
  • Provide an overview of the potential role of CAR T-cells and other cellular therapies in the prevention and treatment of relapse following HSCT.
Additional information
ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
For more information, please contact:
CME Coordinator Contact Name: 
Tracey Pezen
CME Coordinator Contact Email: 
CME Coordinator Contact Phone: 
630-338-8511
Summary
Available credit: 
  • 14.00 AMA PRA Category 1 Credit™
  • 14.00 Participation
Event starts: 
09/21/2018 - 8:10am
Event ends: 
09/22/2018 - 4:00pm
Activity opens: 
09/22/2018
Activity expires: 
03/11/2019
InterContinental Chicago Magnificent Mile
505 Michigan Avenue
Chicago, IL 60611
United States
SPECIAL ATTENDEE RATES AVAILABLE!
Built in 1929, the InterContinental Chicago is a destination on its own and remains a true icon of this great city. Situated right on the Chicago Magnificent Mile, one block north of the Chicago River, attendees have easy access to restaurants, high end shopping, and all the attractions the city has to offer.

Special accomodations are available for workshop attendees. Click below to find out more!

BOOKING INFORMATION
 
 

ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact Tracey Pezen at 630-776-3934 or via email at tpezen@mocandco.com.

PLANNING COMMITTEE
  Michael Bishop, MD
  University of Chicago Medicine​
  Chicago, IL
 
 

  Alan Wayne, MD
  Childrens Hospital Los Angeles,
  USC Norris Comprehensive Cancer Center
  Los Angeles, California
 

  Sergio Giralt, MD
  Memorial Sloan Kettering Cancer Center
  New York, New York
 
 

  Nicolaus Kröger, MD
  University Hospital Hamburg
  Hamburg, Germany
 
 
 

Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Chicago Pritzker School of Medicine and the Organizing Committee. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
 
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 14 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
American Board of Internal Medicine MOC II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 14 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
 
Other Healthcare Professions Credit
Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
 
European Union of Medical Specialties
The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). International physicians interested in converting AMA PRA Category 1 Credit™ to EACCME credit should contact the UEMS.

Accreditation Period

Activity opens: 
09/22/2018
Activity expires: 
03/11/2019
REGISTRATION: For complete activity information, visit the conference website.
 


CLAIMING CREDIT: Enter the access code to unlock the credit claiming process.
 
Please login or create an account to proceed.